Genmab As Stock Performance

Genmab AS Relative Risk vs. Return Landscape

If you would invest  3,057  in Genmab AS on November 19, 2025 and sell it today you would lose (57.00) from holding Genmab AS or give up 1.86% of portfolio value over 90 days. Genmab AS is currently does not generate positive expected returns and assumes 2.2549% risk (volatility on return distribution) over the 90 days horizon. In different words, 20% of stocks are less volatile than Genmab, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Genmab AS is expected to under-perform the market. In addition to that, the company is 2.99 times more volatile than its market benchmark. It trades about 0.0 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.16 per unit of volatility.

Genmab AS Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the stock has the beta coefficient of 1.1 . This usually indicates Genmab AS market returns are sensitive to returns on the market. As the market goes up or down, Genmab AS is expected to follow. Additionally Genmab AS has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Genmab AS

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Genmab AS. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 27.75 30.00 32.25 Details

Intrinsic Valuation Low Real High 27.00 34.58 36.83 Details

9 Analysts Consensus Low Target High 34.52 37.93 42.10 Details

Earnings Estimates (0) Low Projected EPS High 0.46 0.42 0.50 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Genmab AS. Your research has to be compared to or analyzed against Genmab AS's peers to derive any actionable benefits. When done correctly, Genmab AS's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Genmab AS.

Genmab AS Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Genmab AS is not an exception. The market had few large corrections towards the Genmab AS's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Genmab AS, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Genmab AS within the framework of very fundamental risk indicators.

Genmab AS Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Genmab AS for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Genmab AS can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Genmab AS Price Density Drivers

Genmab AS Fundamentals Growth

When running Genmab AS's price analysis, check to measure Genmab AS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genmab AS is operating at the current time. Most of Genmab AS's value examination focuses on studying past and present price action to predict the probability of Genmab AS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genmab AS's price. Additionally, you may evaluate how the addition of Genmab AS to your portfolios can decrease your overall portfolio volatility.